J&J | JNJ - Cash And Equivalent


J&J reported $20.42B in Cash and Equivalent for its fiscal quarter ending in June of 2026.





Cash And Equivalent Change Date
AbbVie USD 6.57B 2.82B Jun/2026
Abbott USD 6.8B 1.72B Mar/2026
Amgen USD 13.99B 1.95B Jun/2026
AstraZeneca USD 4.89B 2.67B Jun/2026
Baxter International USD 2.15B 133M Jun/2026
Bayer EUR 5.73B 943M Mar/2026
Becton, Dickinson and Co. USD 708M 105M Jun/2026
Biogen USD 1.28B 2.1B Jun/2026
Boston Scientific USD 539M 914M Jun/2026
Bristol-Myers Squibb USD 8.72B 852M Jun/2026
CONMED USD 35.03M 5.79M Mar/2026
Cooper Companies USD 124.9M 14.3M Dec/2025
Dexcom USD 1.1B 13.2M Jun/2026
Edwards Lifesciences USD 2.9B 500M Jun/2026
Eli Lilly USD 8.95B 3.67B Jun/2026
Gilead Sciences USD 7.63B 64M Mar/2026
GlaxoSmithKline GBP 3.44B 292M Mar/2026
Globus Medical USD 507.74M 53.2M Jun/2026
Insulet USD 534.9M 54.5M Jun/2026
Integra LifeSciences USD 214.42M 22.39M Jun/2026
Intuitive Surgical USD 8.63B 646.3M Jun/2026
J&J USD 20.42B 1.27B Jun/2026
Medtronic USD 1.15B 135M Dec/2025
Merck USD 6.85B 1.52B Jun/2026
Merit Medical Systems USD 448.7M 39.38M Jun/2026
Novartis USD 7.62B 739M Jun/2026
Pfizer USD 976M 727M Jun/2026
Regeneron Pharmaceuticals USD 2.46B 506.8M Jun/2026
Roche Holding CHF 7.55B 579M Jun/2025
Sanofi EUR 6.35B 806M Jun/2026
Stryker USD 3.39B 513M Jun/2026
Tandem Diabetes Care USD 62.82M 116.51M Jun/2026
Teva Pharmaceutical Industries USD 3.74B 185M Mar/2026
Vertex Pharmaceuticals USD 7.85B 605.7M Jun/2026
Zimmer Biomet Holdings USD 410M 14.2M Jun/2026
Zoetis USD 1.48B 465M Jun/2026